A year-long study published by The American Journal of Pharmacy Benefits in 2012,analyzed the results of oral oncology medications on cost and patient outcomes. It concluded that specialty pharmacy programs promoting oral oncology drugs in treatment regiments increased patient adherence and lowered overall medical costs by 13 percent, or about $13,000, in the first year of treatment. According to the study, the savings largely resulted from a reduction in outpatient hospital costs by more than 40 percent.
Over the past decade oncology treatments have shifted toward increased use of highly targeted oral medications. This has enabled patients to receive treatment at home rather than in an inpatient or outpatient setting.